RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5
Lanario, J W, Hyland, M E, Menzies-Gow, A, Mansur, A H, Dodd, J W, Fowler, S J, Jones, R C & Masoli, M 2020, ' Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA) ', Health and Quality of Life Outcomes, vol. 18, no. 1, 336 . https://doi.org/10.1186/s12955-020-01593-9 Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020) Lanario, J W, Hyland, M E, Menzies-Gow, A, Mansur, A H, Dodd, J W, Fowler, S J, Jones, R C & Masoli, M 2020, ' Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA) ', Health and Quality of Life Outcomes, vol. 18, no. 1, 336, pp. 336 . https://doi.org/10.1186/s12955-020-01593-9 Health and Quality of Life Outcomes